Cardinal Health (CAH) Projected to Post Quarterly Earnings on Thursday

Cardinal Health (NYSE:CAH) is expected to be releasing its earnings data before the market opens on Thursday, January 30th. Analysts expect Cardinal Health to post earnings of $1.74 per share and revenue of $53,904,600.00 billion for the quarter. Cardinal Health has set its FY25 guidance at $7.75-7.90 EPS and its FY 2025 guidance at 7.750-7.900 EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

Cardinal Health (NYSE:CAH) last posted its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.73 earnings per share. On average, analysts expect Cardinal Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Cardinal Health Trading Up 1.4 %

NYSE:CAH opened at $130.65 on Tuesday. The business’s 50-day moving average is $121.57 and its 200 day moving average is $113.42. Cardinal Health has a 12 month low of $93.17 and a 12 month high of $131.00. The company has a market capitalization of $31.62 billion, a P/E ratio of 25.42, a P/E/G ratio of 1.57 and a beta of 0.63.

Cardinal Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were paid a dividend of $0.5056 per share. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.55%. Cardinal Health’s payout ratio is currently 39.30%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Citigroup upped their target price on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective on the stock. Finally, JPMorgan Chase & Co. increased their price objective on Cardinal Health from $132.00 to $142.00 and gave the stock a “neutral” rating in a research note on Friday. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $134.64.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.